<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1241" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1241/" /><meta name="ncbi_pagename" content="Ataxia with Vitamin E Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Ataxia with Vitamin E Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Ataxia with Vitamin E Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/10/13" /><meta name="citation_author" content="Markus Schuelke" /><meta name="citation_pmid" content="20301419" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1241/" /><meta name="citation_keywords" content="Ataxia with Isolated Vitamin E Deficiency" /><meta name="citation_keywords" content="AVED" /><meta name="citation_keywords" content="Familial Isolated Vitamin E Deficiency" /><meta name="citation_keywords" content="Friedreich-Like Ataxia" /><meta name="citation_keywords" content="AVED" /><meta name="citation_keywords" content="Ataxia with Isolated Vitamin E Deficiency" /><meta name="citation_keywords" content="Familial Isolated Vitamin E Deficiency" /><meta name="citation_keywords" content="Friedreich-Like Ataxia" /><meta name="citation_keywords" content="Alpha-tocopherol transfer protein" /><meta name="citation_keywords" content="TTPA" /><meta name="citation_keywords" content="Ataxia with Vitamin E Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Ataxia with Vitamin E Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Markus Schuelke" /><meta name="DC.Date" content="2016/10/13" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1241/" /><meta name="description" content="Ataxia with vitamin E deficiency (AVED) generally manifests in late childhood or early teens between ages five and 15 years. The first symptoms include progressive ataxia, clumsiness of the hands, loss of proprioception, and areflexia. Other features often observed are dysdiadochokinesia, dysarthria, positive Romberg sign, head titubation, decreased visual acuity, and positive Babinski sign. The phenotype and disease severity vary widely among families with different pathogenic variants; age of onset and disease course are more uniform within a given family, but symptoms and disease severity can vary even among sibs." /><meta name="og:title" content="Ataxia with Vitamin E Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="Ataxia with vitamin E deficiency (AVED) generally manifests in late childhood or early teens between ages five and 15 years. The first symptoms include progressive ataxia, clumsiness of the hands, loss of proprioception, and areflexia. Other features often observed are dysdiadochokinesia, dysarthria, positive Romberg sign, head titubation, decreased visual acuity, and positive Babinski sign. The phenotype and disease severity vary widely among families with different pathogenic variants; age of onset and disease course are more uniform within a given family, but symptoms and disease severity can vary even among sibs." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1241/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/aved/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1241/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C09BDE04153D100000000021200C0.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1241_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1241_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/aoa2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ataxia-telangiectas/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1241_"><span class="title" itemprop="name">Ataxia with Vitamin E Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Ataxia with Isolated Vitamin E Deficiency, AVED, Familial Isolated Vitamin E Deficiency, Friedreich-Like Ataxia</div><p class="contrib-group"><span itemprop="author">Markus Schuelke</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1241_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1241_ai__"><div class="contrib half_rhythm"><span itemprop="author">Markus Schuelke</span>, MD<div class="affiliation small">Department of Neuropediatrics<br />Charit&#x000e9; &#x00026; NeuroCure Clinical Research Center<br />Charit&#x000e9; - Universit&#x000e4;tsmedizin Berlin<br />Berlin, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.etirahc@ekleuhcs.sukram" class="oemail">ed.etirahc@ekleuhcs.sukram</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 20, 2005</span>; Last Update: <span itemprop="dateModified">October 13, 2016</span>.</p><p><em>Estimated reading time: 24 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="aved.Summary" itemprop="description"><h2 id="_aved_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Ataxia with vitamin E deficiency (AVED) generally manifests in late childhood or early teens between ages five and 15 years. The first symptoms include progressive ataxia, clumsiness of the hands, loss of proprioception, and areflexia. Other features often observed are dysdiadochokinesia, dysarthria, positive Romberg sign, head titubation, decreased visual acuity, and positive Babinski sign. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and disease severity vary widely among families with different pathogenic variants; age of onset and disease course are more uniform within a given family, but symptoms and disease severity can vary even among sibs.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Presently, no consensus diagnostic criteria for AVED exist; the principal criterion for diagnosis is a Friedreich ataxia-like neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> combined with markedly reduced plasma vitamin E (&#x003b1;-tocopherol) concentration and a normal lipoprotein profile in the absence of known causes of malabsorption. Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>TTPA</i> pathogenic variants on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> confirms the diagnosis.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Lifelong high-dose oral vitamin E supplementation to bring plasma vitamin E concentrations into the high-normal range; treatment early in the disease process may to some extent reverse ataxia and mental deterioration.</p><p><i>Prevention of primary manifestations</i>: Vitamin E therapy in presymptomatic children with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>TTPA</i> pathogenic variants prevents development of symptoms.</p><p><i>Surveillance:</i> Monitor plasma vitamin E concentration every six months, particularly in children.</p><p><i>Agents/circumstances to</i>
<i>avoid</i>: Smoking; occupations requiring quick responses or good balance.</p><p><i>Evaluation of relatives at risk</i>: Evaluation for vitamin E deficiency, especially in younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p><i>Other</i>: Before attempting to drive a car, assessment to determine if the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual can drive safely.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>AVED is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes and carry one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; heterozygotes are asymptomatic. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier detection for at-risk family members and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if the pathogenic variants in the family have been identified.</p></div></div><div id="aved.Diagnosis"><h2 id="_aved_Diagnosis_">Diagnosis</h2><div id="aved.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Ataxia with vitamin E deficiency (AVED) <b>should be suspected</b> in individuals who typically present at the beginning of puberty with the following:</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Progressive ataxia</div></li><li class="half_rhythm"><div>Clumsiness of the hands</div></li><li class="half_rhythm"><div>Loss of proprioception (especially distal joint position and vibration sense)</div></li><li class="half_rhythm"><div>Areflexia</div></li><li class="half_rhythm"><div>Dysdiadochokinesia</div></li><li class="half_rhythm"><div>Positive Romberg sign</div></li><li class="half_rhythm"><div>Head titubation</div></li><li class="half_rhythm"><div>Decreased visual acuity</div></li><li class="half_rhythm"><div>Positive Babinski sign</div></li><li class="half_rhythm"><div>Macular atrophy, retinitis pigmentosa</div></li></ul><p><b>Laboratory findings</b></p><ul><li class="half_rhythm"><div>Normal lipid and lipoprotein profile</div></li><li class="half_rhythm"><div>Very low plasma vitamin E (&#x003b1;-tocopherol) concentration</div><div>Note: (1) There is no universal normal range of plasma vitamin E concentration, as it depends on the test method and varies among laboratories. In <a class="bk_pop" href="#aved.REF.finckh.1995.210">Finckh et al [1995]</a>, the normal range lies between 9.0 and 29.8 &#x000b5;mol/L (mean &#x000b1; 2 SD). In <a class="bk_pop" href="#aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al [2014]</a> the normal range is given as 16.3-34.9 &#x000b5;mol/L, while individuals with AVED had vitamin E levels between 0.00 and 3.76 &#x000b5;mol/L (mean 0.95 &#x000b5;mol/L, SD 1.79 &#x000b5;mol/L; n=132). In individuals with AVED, the plasma vitamin E concentration is generally lower than 4.0 &#x000b5;mol/L (&#x0003c;1.7 mg/L) [<a class="bk_pop" href="#aved.REF.cavalier.1998.301">Cavalier et al 1998</a>, <a class="bk_pop" href="#aved.REF.mariotti.2004.130">Mariotti et al 2004</a>]. (2) Because oxidation of &#x003b1;-tocopherol by air may invalidate test results, the following precautions should be taken:</div><ul><li class="half_rhythm"><div>Centrifugation of the EDTA blood soon after venipuncture</div></li><li class="half_rhythm"><div>Quick separation of plasma from blood cells after centrifugation and subsequent flash freezing of the plasma in liquid nitrogen</div></li><li class="half_rhythm"><div>Filling the space above the plasma with an inert gas (e.g., argon or nitrogen)</div></li><li class="half_rhythm"><div>Protecting the sample from light by wrapping the container in aluminum foil, or using a black or light-shielded Eppendorf tube</div></li><li class="half_rhythm"><div>Shipment of the sample to the test laboratory in dry ice</div></li></ul></li></ul><p><b>Electrophysiologic findings</b></p><ul><li class="half_rhythm"><div>In a large study of 132 individuals with AVED from North Africa, 45 individuals were investigated neurophysiologically (e.g., median and peroneal nerve motor conduction velocity, compound muscle action potential, median and saphenous nerve sensory action potential, and sensory action potential) [<a class="bk_pop" href="#aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</a>].</div><ul><li class="half_rhythm"><div>9% had normal findings.</div></li><li class="half_rhythm"><div>47% had mild neuropathy (at least 1 parameter 70%-100% of lower limit of normal [LLN]).</div></li><li class="half_rhythm"><div>27% had moderate neuropathy (at least 1 parameter 30%-70% of LLN).</div></li><li class="half_rhythm"><div>17% had severe neuropathy (at least 1 parameter &#x0003c;30% of LLN or no response).</div></li><li class="half_rhythm"><div>Neuropathy was either purely sensory (34%), purely motor (24%), or combined (42%).</div></li></ul></li><li class="half_rhythm"><div>Somatosensory evoked potentials show increased central conduction time between the segment C1 (N13b) and the sensorimotor cortex (N20), increased latencies of the N20 (median nerve) and P40 (tibial nerve) waves. The P40 wave may be missing completely [<a class="bk_pop" href="#aved.REF.schuelke.1999.240">Schuelke et al 1999</a>].</div></li></ul><p>Note: No electrophysiologic findings are specific to or diagnostic of AVED; even a severe neuropathy does not exclude AVED.</p><p><b>Neuroimaging</b></p><ul><li class="half_rhythm"><div>Cerebellar atrophy [<a class="bk_pop" href="#aved.REF.mariotti.2004.130">Mariotti et al 2004</a>]; present in approximately half of reported individuals</div></li><li class="half_rhythm"><div>Small T<sub>2</sub> high-intensity spots in the periventricular region and the deep white matter [<a class="bk_pop" href="#aved.REF.usuki.2000.254">Usuki &#x00026; Maruyama 2000</a>]; inconsistent finding in some individuals</div></li></ul><p>Note: No radiologic findings are specific to or diagnostic of AVED.</p><p><b>Histopathology findings</b> [<a class="bk_pop" href="#aved.REF.larnaout.1997.633">Larnaout et al 1997</a>, <a class="bk_pop" href="#aved.REF.yokota.2000.521">Yokota et al 2000</a>, <a class="bk_pop" href="#aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</a>, <a class="bk_pop" href="#aved.REF.ulatowski.2014.120">Ulatowski et al 2014</a>]</p><ul><li class="half_rhythm"><div>Spinal sensory demyelination with neuronal atrophy and axonal spheroids</div></li><li class="half_rhythm"><div>Dying back-type degeneration of the posterior columns</div></li><li class="half_rhythm"><div>Neuronal lipofuscin accumulation in the third cortical layer of the cerebral cortex, thalamus, lateral geniculate body, spinal horns, and posterior root ganglia</div></li><li class="half_rhythm"><div>Fiber type grouping of the peroneus brevis muscle</div></li><li class="half_rhythm"><div>Mild loss of Purkinje cells</div></li></ul></div><div id="aved.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>Presently no consensus diagnostic criteria for ataxia with vitamin E deficiency (AVED) exist.</p><p>The diagnosis of AVED <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with all of the following:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/friedreich/">Friedreich ataxia</a>-like neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></div></li><li class="half_rhythm"><div>Markedly reduced plasma vitamin E (&#x003b1;-tocopherol) concentration</div></li><li class="half_rhythm"><div>Normal lipoprotein profile</div></li><li class="half_rhythm"><div>Exclusion of diseases that cause fat malabsorption</div></li></ul><p>Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>TTPA</i> pathogenic variants on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1241/table/aved.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figavedTmoleculargenetictestingusedin" rid-ob="figobavedTmoleculargenetictestingusedin">Table 1</a>) establishes the diagnosis if clinical and laboratory features are inconclusive and confirms the diagnosis in individuals with the above features.</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>TTPA</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found. Targeted analysis for <i>TTPA</i> pathogenic variant <a class="figpopup" href="/books/NBK1241/table/aved.T.ttpa_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figavedTttpapathogenicvariantsdiscusse" rid-ob="figobavedTttpapathogenicvariantsdiscusse">c.744delA</a> can be performed first in individuals of Mediterranean or North African ancestry.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>TTPA</i> and other genes of interest (see <a href="#aved.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included and <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of multigene panels vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) fails to confirm a diagnosis in an individual with features of AVED. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="aved.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Ataxia with Vitamin E Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1241/table/aved.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aved.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>TTPA</i></td><td headers="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;90%&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="aved.TF.1.1"><p class="no_margin">See <a href="/books/NBK1241/#aved.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="aved.TF.1.2"><p class="no_margin">See <a href="#aved.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="aved.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="aved.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#aved.REF.ouahchi.1995.141">Ouahchi et al [1995]</a>, <a class="bk_pop" href="#aved.REF.hentati.1996.295">Hentati et al [1996]</a>, <a class="bk_pop" href="#aved.REF.cavalier.1998.301">Cavalier et al [1998]</a>, Schuelke [personal observation]. Sequence analysis identified at least one abnormal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> in 46 of 51 individuals with the AVED <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, who had clearly reduced plasma vitamin E concentration [Schuelke, personal observation]. In 132 Tunisian individuals with AVED, 91.7% were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <a class="figpopup" href="/books/NBK1241/table/aved.T.ttpa_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figavedTttpapathogenicvariantsdiscusse" rid-ob="figobavedTttpapathogenicvariantsdiscusse">c.744delA</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; 8.3% of individuals were homozygous for other pathogenic variants (c.205-1G&#x0003e;T, c.400C&#x0003e;T, c.552+2T&#x0003e;A) [<a class="bk_pop" href="#aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</a>]. Sequence analysis of <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> was used to confirm a synonymous pathogenic variant resulting in loss of <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> [<a class="bk_pop" href="#aved.REF.schuelke.1999.240">Schuelke et al 1999</a>] (see <a href="#aved.Molecular_Genetics">Molecular Genetics</a>).</p></div></dd><dt>5. </dt><dd><div id="aved.TF.1.5"><p class="no_margin">Most individuals are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for one of the known pathogenic variants.</p></div></dd><dt>6. </dt><dd><div id="aved.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="aved.TF.1.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available. A single whole-gene deletion has been reported [<a class="bk_pop" href="#aved.REF.kara.2008.471">Kara et al 2008</a>].</p></div></dd></dl></div></div></div></div></div><div id="aved.Clinical_Characteristics"><h2 id="_aved_Clinical_Characteristics_">Clinical Characteristics</h2><div id="aved.Clinical_Description"><h3>Clinical Description</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and disease severity of ataxia with vitamin E deficiency (AVED) vary widely. Although age of onset and disease course tend to be more uniform within a given family, symptoms and disease severity can vary among sibs [<a class="bk_pop" href="#aved.REF.shorer.1996.340">Shorer et al 1996</a>].</p><p>AVED generally manifests in late childhood or early teens between ages five and 15 years, however, the range may be from age two to 37 years as reported in a series of 132 North African individuals [<a class="bk_pop" href="#aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</a>]. The first symptoms include progressive ataxia, clumsiness of the hands, and loss of proprioception, especially of vibration and joint position sense. Handwriting deteriorates. In rare individuals, school performance declines secondary to loss of intellectual capacities. Tendon reflexes of the lower extremities are generally absent and the plantar reflexes increase in intensity. Affected individuals have difficulty walking in the dark and often have a positive Romberg sign. A high percentage of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (e.g., 8/11 individuals in one series) experience decreased visual acuity [<a class="bk_pop" href="#aved.REF.benomar.2002.25">Benomar et al 2002</a>].</p><p>In many individuals, cerebellar signs such as dysdiadochokinesia and dysarthria with a scanning speech pattern are present. One third of individuals have a characteristic head tremor (head titubation). In some persons, psychotic episodes, intellectual decline, and dystonic episodes have been described. Rarely, AVED may manifest as arm or cervical dystonia [<a class="bk_pop" href="#aved.REF.becker.2016.374">Becker et al 2016</a>].</p><p>Most untreated individuals become wheelchair dependent as a result of ataxia and/or leg weakness between ages 11 and 50 years [<a class="bk_pop" href="#aved.REF.harding.1985.32">Harding et al 1985</a>, <a class="bk_pop" href="#aved.REF.ouahchi.1995.141">Ouahchi et al 1995</a>, <a class="bk_pop" href="#aved.REF.hentati.1996.295">Hentati et al 1996</a>, <a class="bk_pop" href="#aved.REF.cavalier.1998.301">Cavalier et al 1998</a>, <a class="bk_pop" href="#aved.REF.gabsi.2001.477">Gabsi et al 2001</a>, <a class="bk_pop" href="#aved.REF.benomar.2002.25">Benomar et al 2002</a>, <a class="bk_pop" href="#aved.REF.mariotti.2004.130">Mariotti et al 2004</a>].</p><p>According to a large study on 132 individuals from North Africa [<a class="bk_pop" href="#aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</a>], the signs and symptoms include (in decreasing order of frequency):</p><ul><li class="half_rhythm"><div>Areflexia (94.7%)</div></li><li class="half_rhythm"><div>Gait impairment (93.4%)</div></li><li class="half_rhythm"><div>Positive Babinski sign (85.5%)</div></li><li class="half_rhythm"><div>Deep sensory disturbances (67.1%)</div></li><li class="half_rhythm"><div>Dysarthria (61.8%)</div></li><li class="half_rhythm"><div>Head tremor (40.8%)</div></li><li class="half_rhythm"><div>Urinary urgency (22.4%)</div></li><li class="half_rhythm"><div>Nystagmus (5.3%)</div></li><li class="half_rhythm"><div>Urinary incontinence (4.0%)</div></li><li class="half_rhythm"><div>Retinitis pigmentosa (2.3%)</div></li><li class="half_rhythm"><div>Cardiomyopathy (1.5%)</div></li></ul></div><div id="aved.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>To date, only two pathogenic variants have shown clear-cut <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>:</p><ul><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1241/table/aved.T.ttpa_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figavedTttpapathogenicvariantsdiscusse" rid-ob="figobavedTttpapathogenicvariantsdiscusse"><b>p.His101Gln</b></a> is associated with late-onset disease (age &#x0003e;30 years), a mild course, and increased risk for pigmentary retinopathy. This variant is primarily reported in individuals of Japanese descent.</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1241/table/aved.T.ttpa_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figavedTttpapathogenicvariantsdiscusse" rid-ob="figobavedTttpapathogenicvariantsdiscusse"><b>c.744delA</b></a> is associated with early onset, a severe course, and slightly increased risk for cardiomyopathy. This variant is mainly observed in individuals of Mediterranean or North African descent. However, disease severity may vary considerably, and even in persons from the same family the onset of symptoms may vary between ages three and 12 years [<a class="bk_pop" href="#aved.REF.cavalier.1998.301">Cavalier et al 1998</a>, <a class="bk_pop" href="#aved.REF.marzouki.2005.21">Marzouki et al 2005</a>].</div></li></ul><p>A less clear <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation can be seen for the following pathogenic variants if they occur in <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> form. Manifestation of disease:</p><ul><li class="half_rhythm"><div><b>Before age ten years.</b> p.Arg59Trp, p.Arg134Ter, p.Glu141Lys, c.486delT, c.513_514insTT, c.530-531AG&#x0003e;GTAAGT (see <a class="figpopup" href="/books/NBK1241/table/aved.T.ttpa_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figavedTttpapathogenicvariantsdiscusse" rid-ob="figobavedTttpapathogenicvariantsdiscusse">Table 3</a>)</div></li><li class="half_rhythm"><div><b>After age ten years.</b> p.Arg221Trp, p.Ala120Thr (see <a class="figpopup" href="/books/NBK1241/table/aved.T.ttpa_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figavedTttpapathogenicvariantsdiscusse" rid-ob="figobavedTttpapathogenicvariantsdiscusse">Table 3</a>) [<a class="bk_pop" href="#aved.REF.cavalier.1998.301">Cavalier et al 1998</a>]</div></li></ul></div><div id="aved.Penetrance"><h3>Penetrance</h3><p>AVED shows nearly complete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in individuals who are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for a <i>TTPA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="aved.Nomenclature"><h3>Nomenclature</h3><p>AVED was first called "Friedreich ataxia <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with selective vitamin E deficiency" [<a class="bk_pop" href="#aved.REF.ben_hamida.1993.195">Ben Hamida et al 1993</a>].</p></div><div id="aved.Prevalence"><h3>Prevalence</h3><p>Several restricted population-based studies have been performed.</p><p><a class="bk_pop" href="#aved.REF.gotoda.1995.1313">Gotoda et al [1995]</a> found one <i>TTPA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<a class="figpopup" href="/books/NBK1241/table/aved.T.ttpa_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figavedTttpapathogenicvariantsdiscusse" rid-ob="figobavedTttpapathogenicvariantsdiscusse">p.His101Gln</a>) in 21 of 801 randomly selected inhabitants of a Japanese island on which one individual had previously been diagnosed with AVED. This would amount to a calculated prevalence of one <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> individual per 1500 inhabitants. This pathogenic variant was not detected in 150 unrelated individuals from Tokyo.</p><p>In a Moroccan study, AVED was diagnosed in 20% of individuals with a Friedreich ataxia-like <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [Benomar, personal communication].</p><p>In a population study in southeast Norway, 1 in 171 individuals with hereditary ataxia was found to have AVED, suggesting a prevalence of 0.6:1,000,000 [<a class="bk_pop" href="#aved.REF.elkamil.2015.33">Elkamil et al 2015</a>].</p><p><a class="bk_pop" href="#aved.REF.anheim.2010.1">Anheim et al [2010]</a> evaluated102 individuals with suspected <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> cerebellar ataxia; in 57 individuals (56%) a molecular diagnosis could be established. Of these, 36 had <a href="/books/n/gene/friedreich/">Friedreich ataxia</a> (FRDA), seven had <a href="/books/n/gene/aoa2/">ataxia with oculomotor apraxia type 2</a> (AOA2), four had <a href="/books/n/gene/ataxia-telangiectas/">ataxia-telangiectasia</a> (AT), three had <a href="/books/n/gene/mss/">Marinesco-Sj&#x000f6;gren syndrome</a> (MSS), three had <a href="/books/n/gene/aoa/">ataxia with oculomotor apraxia type 1</a> (AOA1), two had AR spastic ataxia of Charlevoix-Saguenay (<a href="/books/n/gene/arsacs/">ARSACS</a>), one had AR cerebellar ataxia (ARCA2), and one had ataxia with vitamin E deficiency (AVED). From their findings, the authors infer a prevalence for AVED in the Alsace region of France of approximately 1:1,800,000.</p><p><a class="bk_pop" href="#aved.REF.zortea.2004.275">Zortea et al [2004]</a> performed an epidemiologic study of inherited ataxias in the Italian province of Padua and found a prevalence of 3.5:1,000,000 for AVED.</p><p>It also appears to be of interest that <i>TTPA</i> knockout mice are resistant to cerebral malaria and that this resistance can be abrogated by supplementation with vitamin E [<a class="bk_pop" href="#aved.REF.herbas.2010a.200">Herbas et al 2010a</a>, <a class="bk_pop" href="#aved.REF.herbas.2010b.101">Herbas et al 2010b</a>]. This may add <i>TTPA</i> pathogenic variants to several inherited alterations that confer protection against malaria [<a class="bk_pop" href="#aved.REF.l_pez.2010.1">L&#x000f3;pez et al 2010</a>] and could explain the comparatively high prevalence of such pathogenic variants around the Mediterranean Sea.</p></div></div><div id="aved.Genetically_Related_Allelic_Disorde"><h2 id="_aved_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>TTPA</i>.</p></div><div id="aved.Differential_Diagnosis"><h2 id="_aved_Differential_Diagnosis_">Differential Diagnosis</h2><p><a href="/books/n/gene/friedreich/"><b>Friedreich ataxia</b></a>
<b>(FRDA).</b> The age of onset is similar in ataxia with vitamin E deficiency (AVED) and FRDA; however, only in AVED are plasma vitamin E concentrations low [<a class="bk_pop" href="#aved.REF.benomar.2002.25">Benomar et al 2002</a>].</p><p>Certain clinical signs also help distinguish the two disorders (<a class="figpopup" href="/books/NBK1241/table/aved.T.clinical_signs_that_help_distingu/?report=objectonly" target="object" rid-figpopup="figavedTclinicalsignsthathelpdistingu" rid-ob="figobavedTclinicalsignsthathelpdistingu">Table 2</a>); however, the distinction cannot be made on clinical grounds alone.</p><div id="aved.T.clinical_signs_that_help_distingu" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Clinical Signs that Help Distinguish FRDA from AVED</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1241/table/aved.T.clinical_signs_that_help_distingu/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aved.T.clinical_signs_that_help_distingu_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Sign</th><th id="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">FRDA</th><th id="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AVED</th></tr></thead><tbody><tr><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cavus foot</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td></tr><tr><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Peripheral neuropathy</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild</td></tr><tr><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Diabetes mellitus type I</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(+)</td></tr><tr><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Head titubation (tremor)</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Amyotrophy</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td></tr><tr><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Babinski sign</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(+)</td></tr><tr><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dystonia</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Retinitis pigmentosa</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(+)</td></tr><tr><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reduced visual acuity</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiac conduction disorder</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td></tr><tr><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiomyopathy</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(+)</td></tr><tr><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Muscle weakness</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td></tr><tr><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Diabetes mellitus</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>+ </dt><dd><div id="aved.TF.2.1"><p class="no_margin">= generally present; (+) = present only with certain pathogenic variants; &#x02013; = generally absent</p></div></dd></dl></div></div></div><p>FRDA can be diagnosed based on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> and AVED based on plasma &#x003b1;-tocopherol concentration and molecular genetic testing of <i>TTPA</i>. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><a href="/books/n/gene/ab-lipo-p/"><b>Abetalipoproteinemia</b></a>
<b>(Bassen-Kornzweig) and hypobetalipoproteinemia</b>. Features include retinitis pigmentosa, progressive ataxia, steatorrhea, demyelinating neuropathy, dystonia, extrapyramidal signs, spastic paraparesis (rare), and acanthocytosis together with vitamin E deficiency, which is secondary to defective intestinal absorption of lipids. The serum cholesterol concentration is very low, and serum &#x003b2;-lipoproteins are absent. Low-density lipoproteins (LDLs) and very low-density lipoproteins (VLDLs) cannot be synthesized properly. Abetalipoproteinemia is caused by pathogenic variants in <i>MTP</i>, which encodes microsomal triglyceride transfer protein large subunit. Hypobetalipoproteinemia (OMIM <a href="http://omim.org/entry/615558" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615558</a>, <a href="http://omim.org/entry/605019" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">605019</a>) is caused by pathogenic variants in <i>APOB</i> (encoding apolipoprotein B-100) or <i>ANGPTL3</i> (encoding angiopoietin-related protein 3). Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><b>Malnutrition/reduced vitamin E uptake.</b> To become vitamin E deficient, healthy individuals have to consume a diet depleted in vitamin E over months. This is sometimes seen in individuals, especially children, who eat a highly unbalanced diet (e.g., Zen macrobiotic diet), but is most often observed in chronic diseases that impede the resorption of fat-soluble vitamins in the distal ileum (e.g., cholestatic liver disease, short bowel syndrome, <a href="/books/n/gene/cf/">cystic fibrosis</a>, Crohn's disease). The symptoms are similar to AVED. Although such individuals should be supplemented with oral preparations of vitamin E, they do not need the high doses necessary for treatment of AVED.</p><p><a href="/books/n/gene/refsum/"><b>Refsum disease</b></a><b>.</b> Findings are early-onset retinitis pigmentosa, chronic polyneuropathy, deafness, and cerebellar ataxia. Many individuals have cardiac conduction disorders and ichthyosis. In Refsum disease, the degradation of phytanic acid is impeded because of pathogenic variants in the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding phytanoyl-CoA hydroxylase (<i>PHYH</i>) or the gene encoding the PTS2 receptor (<i>PEX7</i>). High serum concentration of phytanic acid differentiates Refsum disease from AVED. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><b>Charcot-Marie-Tooth neuropathy type 1A (CMT1A).</b> Findings are sensorimotor neuropathy with areflexia, cavus foot, and muscle wasting and weakness, especially in the lower legs and of the interdigital muscles. Neuropathy can be verified by presence of reduced NCVs (&#x0003c;38 m/s). CMT1A is caused by <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of <i>PMP22,</i> the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding peripheral myelin protein 22. The plasma vitamin E concentrations in CMT1A are normal. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>. See <a href="/books/n/gene/cmt/">CMT Overview</a>.</p><p><a href="/books/n/gene/aoa/"><b>Ataxia with oculomotor apraxia type 1</b></a>
<b>(AOA1).</b> Findings are oculomotor apraxia, cerebellar ataxia, peripheral neuropathy, and choreoathetosis. Hypoalbuminemia and hypercholesterolemia may occur. AOA1 neurologically mimics ataxia-telangiectasia, but without telangiectasias or immunodeficiency. Plasma vitamin E levels are normal [<a class="bk_pop" href="#aved.REF.anheim.2010.1">Anheim et al 2010</a>]. AOA1 is caused by pathogenic variants in the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding aprataxin (<i>APTX</i>). Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><a href="/books/n/gene/aoa2/"><b>Ataxia with oculomotor apraxia type 2</b></a>
<b>(AOA2).</b> Findings are spinocerebellar ataxia and, rarely, oculomotor apraxia. Serum concentrations of creatine kinase, &#x003b3;-globulin, and &#x003b1;-fetoprotein (AFP) are increased. AOA2 is caused by pathogenic variants in <i>SETX</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding probable helicase senataxin. Plasma vitamin E levels are normal [<a class="bk_pop" href="#aved.REF.anheim.2010.1">Anheim et al 2010</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><b>Other ataxias.</b> Because AVED typically presents with ataxia or clumsiness in late childhood, AVED should be included in the differential diagnosis of all ataxias with the same age of onset (see <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>), including the following:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/ataxia-telangiectas/"><b>Ataxia-telangiectasia</b></a><b>.</b> Findings are cerebellar ataxia, seizures, nystagmus, conjunctival telangiectasias, hypogonadism, immunodeficiency, frequent pulmonary infections, and neoplasia. Plasma vitamin E levels are normal [<a class="bk_pop" href="#aved.REF.anheim.2010.1">Anheim et al 2010</a>]. Ataxia-telangiectasia is caused by pathogenic variants in <i>ATM</i>; inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/mss/"><b>Marinesco-Sj&#x000f6;gren syndrome</b></a><b>.</b> Findings are cerebellar ataxia, intellectual disability, dysarthria, cataracts, short stature, and hypergonadotropic hypogonadism. Marinesco-Sj&#x000f6;gren syndrome is caused by pathogenic variants in <i>SIL1</i>; inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div><b>Chylomicron retention disease (Anderson disease)</b> (OMIM <a href="http://omim.org/entry/246700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">246700</a>). Clinical findings are infantile-onset malabsorption of fat and fat-soluble vitamins, diarrhea, and neurologic deficits (peripheral neuropathy, absent tendon reflexes, diminished vibratory sense). The disease is caused by pathogenic variants in <i>SAR1B</i> that cause the absence of chylomicrons due to a defect of chylomicron secretion [<a class="bk_pop" href="#aved.REF.aguglia.2000.260">Aguglia et al 2000</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/ccfdn/"><b>Congenital cataracts, facial dysmorphism, neuropathy</b></a><b>.</b> Clinical findings are <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts, cerebellar ataxia, cavus foot deformity, facial dysmorphisms, delayed motor development, and pyramidal signs. The <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are of Roma/Gypsy origin and are all <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 6 of <i>CTDP1</i>. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div><b>Pyruvate dehydrogenase E1 alpha deficiency</b> (OMIM <a href="http://omim.org/entry/312170" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">312170</a>)<b>.</b> Findings are episodic ataxia, intellectual disability, hypotonia, cerebellar atrophy, dystonia, and lactic acidosis. The disease is caused by pathogenic variants in <i>PDHA1</i>; inheritance is <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>. A high proportion of <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females manifest severe symptoms.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/sider-anemia/"><b>Sideroblastic anemia and ataxia</b></a><b>.</b> Findings are early-onset non-progressive cerebellar ataxia, hyperreflexia, tremor, dysdiadochokinesia, and hypochromic microcytic anemia. The disease is caused by pathogenic variants in <i>ABCB7</i>; inheritance is <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>.</div></li><li class="half_rhythm"><div><b>Cayman-type cerebellar ataxia</b> (OMIM <a href="http://omim.org/entry/601238" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601238</a>). Findings are cerebellar ataxia with wide-based gait, psychomotor retardation, intention tremor, and dysarthria. The disease is caused by pathogenic variants in <i>ATCAY</i>; inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/syne1ca-ar/"><b><i>SYNE1</i>-related autosomal recessive cerebellar ataxia</b></a> (also known as <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> spinocerebellar ataxia [SCAR8] and autosomal recessive cerebellar ataxia type 1 [ARCA1]). Findings are adult-onset cerebellar ataxia and/or dysarthria. Dysmetria, brisk lower-extremity tendon reflexes, and minor abnormalities in ocular saccades and pursuit can be seen. ARCA1 has not been observed outside of Quebec, Canada.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/joubert/"><b>Joubert syndrome</b></a><b>.</b> Findings are truncal ataxia, developmental delays, episodic hyperpnea or apnea, and atypical eye movements. Cognitive abilities range from severe intellectual disability to normal. Variable features include retinal dystrophy, renal disease, ocular coloboma, occipital encephalocele, hepatic fibrosis, polydactyly, oral hamartomas, and endocrine abnormalities. The characteristic finding on MRI is the "molar tooth sign" in which hypoplasia of the cerebellar vermis and accompanying brain stem abnormalities resemble a tooth. More than twenty genes are associated with Joubert syndrome (pathogenic variants in which appear to account for only about 50% of cases). Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/ctx/"><b>Cerebrotendinous xanthomatosis</b></a><b>.</b> Clinical features include xanthomas of the Achilles and other tendons, cerebellar ataxia beginning after puberty, juvenile cataracts, early atherosclerosis, and progressive dementia. The disease is caused by pathogenic variants in <i>CYP27A1</i> (encoding sterol 27-hydroxylase, mitochondrial). Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li></ul></div><div id="aved.Management"><h2 id="_aved_Management_">Management</h2><div id="aved.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with ataxia with vitamin E deficiency (AVED), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Clinical neurologic examination &#x02013; particularly reflex status, vibratory and position sense, gait, Babinski sign, tremor, dysarthria</div></li><li class="half_rhythm"><div>Ophthalmologic examination for evidence of macular degeneration or retinitis pigmentosa and decreased visual acuity; electroretinogram (ERG)</div></li><li class="half_rhythm"><div>Cardiac examination; echocardiography and ECG to assess for cardiomyopathy</div></li><li class="half_rhythm"><div>Neurophysiologic examination; nerve conduction velocity (NCV) and somatosensory potentials (especially the central conduction time [<a class="bk_pop" href="#aved.REF.schuelke.1999.240">Schuelke et al 1999</a>]), which are good objective measures of neurologic improvement after vitamin E supplementation</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="aved.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The treatment of choice for AVED is lifelong high-dose oral vitamin E supplementation. Some symptoms (e.g., ataxia and intellectual deterioration) can be reversed if treatment is initiated early in the disease process [<a class="bk_pop" href="#aved.REF.schuelke.1999.240">Schuelke et al 1999</a>]. In older individuals, disease progression can be stopped, but deficits in proprioception and gait unsteadiness generally remain [<a class="bk_pop" href="#aved.REF.gabsi.2001.477">Gabsi et al 2001</a>, <a class="bk_pop" href="#aved.REF.mariotti.2004.130">Mariotti et al 2004</a>, <a class="bk_pop" href="#aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</a>]. With treatment, plasma vitamin E concentrations can become normal.</p><p>In presymptomatic individuals, the manifestations of AVED can be prevented if vitamin E supplementation is initiated early [<a class="bk_pop" href="#aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</a>].</p><p>No large-scale therapeutic studies have been performed to determine optimal vitamin E dosage and to evaluate outcomes.</p><p>The reported vitamin E dose ranges from 800 mg to 1500 mg (or 40 mg/kg body weight in children) [<a class="bk_pop" href="#aved.REF.burck.1981.267">Burck et al 1981</a>, <a class="bk_pop" href="#aved.REF.harding.1985.32">Harding et al 1985</a>, <a class="bk_pop" href="#aved.REF.amiel.1995.333">Amiel et al 1995</a>, <a class="bk_pop" href="#aved.REF.cavalier.1998.301">Cavalier et al 1998</a>, <a class="bk_pop" href="#aved.REF.schuelke.1999.240">Schuelke et al 1999</a>, <a class="bk_pop" href="#aved.REF.schuelke.2000b.1584">Schuelke et al 2000b</a>, <a class="bk_pop" href="#aved.REF.gabsi.2001.477">Gabsi et al 2001</a>, <a class="bk_pop" href="#aved.REF.mariotti.2004.130">Mariotti et al 2004</a>].</p><p>One of the following vitamin E preparations is used:</p><ul><li class="half_rhythm"><div>The chemically manufactured racemic form, <i>all-rac</i>-&#x003b1;-tocopherol acetate</div></li><li class="half_rhythm"><div>The naturally occurring form, <i>RRR</i>-&#x003b1;-tocopherol</div></li></ul><p>It is currently unknown whether <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals should be treated with <i>all-rac</i>-&#x003b1;-tocopherol acetate or with <i>RRR</i>-&#x003b1;-tocopherol. It is known that alpha-TTP (&#x003b1;TPP) stereoselectively binds and transports <i>2R</i>-&#x003b1;-tocopherols [<a class="bk_pop" href="#aved.REF.weiser.1996.2539">Weiser et al 1996</a>, <a class="bk_pop" href="#aved.REF.hosomi.1997.105">Hosomi et al 1997</a>, <a class="bk_pop" href="#aved.REF.leonard.2002.555">Leonard et al 2002</a>]. For some <i>TTPA</i> pathogenic variants, this stereoselective binding capacity is lost and affected individuals cannot discriminate between <i>RRR</i>- and <i>SRR</i>-&#x003b1;-tocopherol [<a class="bk_pop" href="#aved.REF.traber.1993.201">Traber et al 1993</a>, <a class="bk_pop" href="#aved.REF.cavalier.1998.301">Cavalier et al 1998</a>]. In this instance, affected individuals would also be able to incorporate non-<i>2R</i>-&#x003b1;-tocopherol stereoisomers into their bodies if they were supplemented with <i>all-rac</i>-&#x003b1;-tocopherol. Since potential adverse effects of the synthetic stereoisomers have not been studied in detail, it seems appropriate to treat with <i>RRR</i>-&#x003b1;-tocopherol, despite the higher cost.</p></div><div id="aved.Prevention_of_Primary_Manifestation"><h3>Prevention of Primary Manifestations</h3><p>If vitamin E treatment is initiated in presymptomatic individuals (e.g., younger sibs of an index case), the symptoms of AVED do not develop [<a class="bk_pop" href="#aved.REF.amiel.1995.333">Amiel et al 1995</a>, <a class="bk_pop" href="#aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</a>].</p></div><div id="aved.Surveillance"><h3>Surveillance</h3><p>During vitamin E therapy, the plasma vitamin E concentration should be measured at regular intervals (e.g., every 6 months), especially in children. Ideally the plasma vitamin E concentration should be maintained in the high normal range.</p><p>Some protocols call for measuring the total radical-trapping antioxidant parameter of plasma (TRAP). Although &#x003b1;-tocopherol only contributes 5%-10% to TRAP, this parameter appears to be the best surrogate marker for clinical improvement [<a class="bk_pop" href="#aved.REF.schuelke.1999.240">Schuelke et al 1999</a>]. Discontinuation of vitamin E supplementation, even temporarily, leads to a drop in plasma vitamin E concentration within two to three days and to a prolonged drop in TRAP, even after reinitiating vitamin E supplementation [<a class="bk_pop" href="#aved.REF.kohlsch_tter.1997.581">Kohlsch&#x000fc;tter et al 1997</a>, <a class="bk_pop" href="#aved.REF.schuelke.2000b.1584">Schuelke et al 2000b</a>].</p></div><div id="aved.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Individuals with AVED should avoid:</p><ul><li class="half_rhythm"><div>Smoking because it considerably lowers TRAP and reduces plasma vitamin E concentrations [<a class="bk_pop" href="#aved.REF.sharpe.1996.223">Sharpe et al 1996</a>];</div></li><li class="half_rhythm"><div>Occupations requiring quick responses or good balance.</div></li></ul></div><div id="aved.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Predictive testing should be offered to all sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, as timely treatment with vitamin E supplementation may completely avert the clinical manifestations of the disease.</p><ul><li class="half_rhythm"><div>All relatives at risk, especially younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, should be evaluated for vitamin E deficiency.</div></li><li class="half_rhythm"><div>If plasma vitamin E concentration is low, the person should be tested for presence of the <i>TTPA</i> pathogenic variants found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> so that individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants can be treated promptly with vitamin E supplementation.</div></li></ul><p>See <a href="#aved.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="aved.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Reduced vitamin E levels are associated with low fertility and embryo resorption in mice [<a class="bk_pop" href="#aved.REF.traber.2012.330">Traber &#x00026; Manor 2012</a>] and &#x003b1;-tocopherol transfer protein is highly expressed in the human placenta [<a class="bk_pop" href="#aved.REF.m_llerschmehl.2004.413">M&#x000fc;ller-Schmehl et al 2004</a>]; therefore, it is advisable to keep vitamin E levels in the high normal range during pregnancy.</p></div><div id="aved.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="aved.Other"><h3>Other</h3><p>Because of abnormal position sense in the extremities, individuals with AVED may have difficulty riding a bicycle or driving a car. Before attempting to drive a car, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals need to be tested by a physician to determine whether they can drive safely.</p></div></div><div id="aved.Genetic_Counseling"><h2 id="_aved_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="aved.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Ataxia with vitamin E deficiency (AVED) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="aved.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>TTPA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with AVED are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TTPA</i>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TTPA</i>.</p></div><div id="aved.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>TTPA</i> pathogenic variants in the family.</p><p>The moderately lowered plasma vitamin E concentration in heterozygotes is not a sensitive enough measure to distinguish between <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> carriers and non-carriers.</p></div><div id="aved.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Predictive testing of at-risk family members.</b> Because vitamin E treatment initiated in presymptomatic individuals can prevent the findings of AVED [<a class="bk_pop" href="#aved.REF.amiel.1995.333">Amiel et al 1995</a>], predictive testing of at-risk family members (particularly younger sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>) is appropriate. See Management, <a href="#aved.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="aved.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>TTPA</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for AVED are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="aved.Resources"><h2 id="_aved_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Organization for Rare Disorders (NORD)</b></div><div><b>Phone:</b> 203-744-0100</div><div><b>Fax:</b> 203-263-9938</div><div><a href="https://rarediseases.org/rare-diseases/ataxia-with-vitamin-e-deficiency/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ataxia with Vitamin E Deficiency</a></div></li><li class="half_rhythm"><div><b>euro-ATAXIA (European Federation of Hereditary Ataxias)</b></div><div>Ataxia UK</div><div>Lincoln House, Kennington Park, 1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 207 582 1444</div><div><b>Email:</b> smillman@ataxia.org.uk</div><div><a href="https://www.euroataxia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euroataxia.org</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li></ul></div><div id="aved.Molecular_Genetics"><h2 id="_aved_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="aved.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Ataxia with Vitamin E Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1241/table/aved.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aved.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_aved.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_aved.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_aved.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_aved.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_aved.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_aved.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_aved.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7274" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TTPA</i></a></td><td headers="hd_b_aved.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7274" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8q12<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_aved.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P49638" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Alpha-tocopherol transfer protein</a></td><td headers="hd_b_aved.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/TTPA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TTPA database</a></td><td headers="hd_b_aved.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TTPA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TTPA</a></td><td headers="hd_b_aved.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TTPA[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TTPA</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="aved.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="aved.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Ataxia with Vitamin E Deficiency (<a href="/omim/277460,600415" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1241/table/aved.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aved.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/277460" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">277460</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF; VED</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600415" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600415</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TOCOPHEROL TRANSFER PROTEIN, ALPHA; TTPA</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>TTPA</i> consists of five uniformly spliced exons (ENST00000260116) with an <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> of 834 bp. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1241/#aved.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Pathogenic variants of <i>TTPA</i> comprise <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants as well as small deletions, insertions, and indels (i.e., simultaneous <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> and <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>) (see <a class="figpopup" href="/books/NBK1241/table/aved.T.ttpa_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figavedTttpapathogenicvariantsdiscusse" rid-ob="figobavedTttpapathogenicvariantsdiscusse">Table 3</a>). Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have <a class="def" href="/books/n/gene/glossary/def-item/private/">private</a> pathogenic variants. Only the c.744delA and the c.513_514insTT pathogenic variants occur more often, especially in individuals of Mediterranean or North African descent. In a study of 33 individuals with AVED, the c.744delA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was found on both alleles in 11 individuals and on one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> in one individual [<a class="bk_pop" href="#aved.REF.cavalier.1998.301">Cavalier et al 1998</a>]. Putative splice defects can be investigated experimentally by analysis of <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> from Epstein-Barr virus (EBV)-immortalized lymphoblastoid cell lines [<a class="bk_pop" href="#aved.REF.schuelke.1999.240">Schuelke et al 1999</a>].</p><p>For more information, see <a href="/books/NBK1241/#aved.molgen.TA">Table A</a>.</p><div id="aved.T.ttpa_pathogenic_variants_discusse" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>TTPA</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1241/table/aved.T.ttpa_pathogenic_variants_discusse/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aved.T.ttpa_pathogenic_variants_discusse_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.175C&#x0003e;T</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg59Trp</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_3" rowspan="14" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nucleotide/50592999" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000370<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/4507723" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000361<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.191A&#x0003e;G</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp64Gly</td></tr><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.303T&#x0003e;G</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His101Gln</td></tr><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.358G&#x0003e;A</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala120Thr</td></tr><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.400C&#x0003e;T</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg134Ter</td></tr><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.421G&#x0003e;A</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu141Lys</td></tr><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.486delT</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp163GlyfsTer13</td></tr><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.513_514insTT</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr172LeufsTer5</td></tr><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.530-531AG&#x0003e;GTAAGT</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys177SerfsTer3</td></tr><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.548T&#x0003e;C</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu183Pro</td></tr><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.575G&#x0003e;A</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg192His</td></tr><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.661C&#x0003e;T</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg221Trp</td></tr><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.736G&#x0003e;C</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly246Arg</td></tr><tr><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.744delA</td><td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu249AsnfsTer15</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The transcript encodes the 278-amino acid protein, &#x003b1;-tocopherol transfer protein (&#x003b1;TTP). This cytosolic 31.7-kd protein is mainly expressed in liver cells [<a class="bk_pop" href="#aved.REF.sato.1993.17705">Sato et al 1993</a>] but also in the pyramidal cells of the cerebellum [<a class="bk_pop" href="#aved.REF.hosomi.1998.159">Hosomi et al 1998</a>, <a class="bk_pop" href="#aved.REF.copp.1999.80">Copp et al 1999</a>] and in the placenta [<a class="bk_pop" href="#aved.REF.kaempfrotzoll.2003.439">Kaempf-Rotzoll et al 2003</a>, <a class="bk_pop" href="#aved.REF.m_llerschmehl.2004.413">M&#x000fc;ller-Schmehl et al 2004</a>].</p><p>Liver-&#x003b1;TPP incorporates the &#x003b1;-tocopherol from the chylomicrons into VLDLs, which are then secreted into the circulation [<a class="bk_pop" href="#aved.REF.traber.1990.397">Traber et al 1990</a>] &#x02013; a stereoselective process that favors <i>2R</i>-&#x003b1;-tocopherols [<a class="bk_pop" href="#aved.REF.weiser.1996.2539">Weiser et al 1996</a>, <a class="bk_pop" href="#aved.REF.leonard.2002.555">Leonard et al 2002</a>]. In the absence of &#x003b1;TPP, &#x003b1;-tocopherol is rapidly lost into the urine [<a class="bk_pop" href="#aved.REF.schuelke.2000a.1543">Schuelke et al 2000a</a>]. Alpha TTP appears to have two functions that can be tested separately: (1) the stereoselective binding of <i>2R</i>-&#x003b1;-tocopherols and (2) the transfer of &#x003b1;-tocopherol between membranes [<a class="bk_pop" href="#aved.REF.gotoda.1995.1313">Gotoda et al 1995</a>, <a class="bk_pop" href="#aved.REF.morley.2004.4143">Morley et al 2004</a>]. In the hepatocytes, &#x003b1;TPP appears to direct vitamin E trafficking from the endocytic compartment to transport vesicles that deliver the vitamin to the site of secretion at the plasma membrane. In the presence of <i>TTPA</i> pathogenic variants (p.Arg59Trp, p.Arg221Trp, p.Ala120Thr), vitamin E did not travel to the plasma membrane and remained trapped in the lysosomes. The authors also reported that the impact of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on protein stability appears to be directly related to the clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#aved.REF.qian.2006.8236">Qian et al 2006</a>].</p><p>Alpha-TTP has two CRAL-TRIO domains (AA 11-83 and 89-275). These domains were first described in the cellular retinaldehyde-binding protein (CRALBP) and the trifunctional protein (TRIO) [<a class="bk_pop" href="#aved.REF.crabb.1988.18678">Crabb et al 1988</a>, <a class="bk_pop" href="#aved.REF.debant.1996.5466">Debant et al 1996</a>]. Other proteins of this family include a phosphatidyl inositol/phosphatidyl choline transfer protein (Sec14p) of yeast [<a class="bk_pop" href="#aved.REF.sha.1998.506">Sha et al 1998</a>] and the tocopherol-associated protein (TAP or SEC14 like 2) [<a class="bk_pop" href="#aved.REF.zimmer.2000.25672">Zimmer et al 2000</a>]. Pathogenic variants in caytaxin, another CRAL-TRIO protein, cause ataxia in humans (Cayman ataxia) as well [<a class="bk_pop" href="#aved.REF.bomar.2003.264">Bomar et al 2003</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Fourteen of 26 known pathogenic variants in <i>TTPA</i> predict a truncated protein through missplicing or generation of a premature termination codon. Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that cause substitutions in non- or semi-conserved amino acids (e.g., p.His101Gln, p.Ala120Thr, p.Arg192His, or p.Gly246Arg) cause a mild <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, whereas substitutions in highly conserved amino acids are associated with early onset and severe symptoms (e.g., p.Arg59Trp, p.Asp64Gly, p.Glu141Lys, p.Leu183Pro, p.Arg221Trp).</p><p>Through the x-ray crystallographic structure of &#x003b1;TPP [<a class="bk_pop" href="#aved.REF.meier.2003.725">Meier et al 2003</a>, <a class="bk_pop" href="#aved.REF.min.2003.14713">Min et al 2003</a>], the impact of some pathogenic variants on the protein structure and function may be explained. Of ten pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, only one (p.Leu183Pro) is located in the &#x003b1;-tocopherol binding pouch. There is a highly positively charged arginine cluster on the surface of the protein, where &#x003b1;TPP probably interacts with other binding partners. Pathogenic variants of these conserved amino acids, Arg59 and Arg221 cause a severe AVED <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Biochemical investigations of the in vitro capacity of &#x003b1;TPP to bind and to transfer &#x003b1;-tocopherol revealed a reduction in both functions for the p.Arg59Trp, p.Glu141Lys, and p.Arg221Trp pathogenic variants. In contrast, the pathogenic variants associated with the mild AVED <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (p.His101Gln, p.Ala120Thr) do not have a pronounced effect on &#x003b1;TPP in vitro function. It has been hypothesized that the pathology of these pathogenic variants may derive from other as-yet-unknown &#x003b1;TPP functions [<a class="bk_pop" href="#aved.REF.morley.2004.4143">Morley et al 2004</a>]. Both types of pathogenic variants may impair the ability of &#x003b1;TPP to facilitate the secretion of vitamin E from cells where it remains trapped in lysosomes [<a class="bk_pop" href="#aved.REF.qian.2006.8236">Qian et al 2006</a>]. On the other hand, binding of vitamin E to &#x003b1;TPP prevents its ubiquinylation and its subsequent proteolytic degradation through the proteasome [<a class="bk_pop" href="#aved.REF.thakur.2010.9339">Thakur et al 2010</a>].</p></div><div id="aved.References"><h2 id="_aved_References_">References</h2><div id="aved.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="aved.REF.aguglia.2000.260">Aguglia U, Annesi G, Pasquinelli G, Spadafora P, Gambardella A, Annesi F, Pasqua AA, Cavalcanti F, Crescibene L, Bagala A, Bono F, Oliveri RL, Valentino P, Zappia M, Quattrone A. Vitamin E deficiency due to chylomicron retention disease in Marinesco-Sjogren syndrome. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">47</span>:260–4.</span> [<a href="/pubmed/10665502" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10665502</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.amiel.1995.333">Amiel J, Maziere JC, Beucler I, Koenig M, Reutenauer L, Loux N, Bonnefont D, Feo C, Landrieu P. Familial isolated vitamin E deficiency. Extensive study of a large family with a 5-year therapeutic follow-up. <span><span class="ref-journal">J Inherit Metab Dis. </span>1995;<span class="ref-vol">18</span>:333–40.</span> [<a href="/pubmed/7474901" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7474901</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.anheim.2010.1">Anheim M, Fleury M, Monga B, Laugel V, Chaigne D, Rodier G, Ginglinger E, Boulay C, Courtois S, Drouot N, Fritsch M, Delaunoy JP, Stoppa-Lyonnet D, Tranchant C, Koenig M. Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. <span><span class="ref-journal">Neurogenetics. </span>2010;<span class="ref-vol">11</span>:1–12.</span> [<a href="/pubmed/19440741" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19440741</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.becker.2016.374">Becker AE, Vargas W, Pearson TS. Ataxia with Vitamin E Deficiency May Present with Cervical Dystonia. <span><span class="ref-journal">Tremor Other Hyperkinet Mov (N Y). </span>2016;<span class="ref-vol">6</span>:374.</span> [<a href="/pmc/articles/PMC4884265/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4884265</span></a>] [<a href="/pubmed/27274910" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27274910</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.ben_hamida.1993.195">Ben Hamida C, Doerflinger N, Belal S, Linder C, Reutenauer L, Dib C, Gyapay G, Vignal A, Le Paslier D, Cohen D, Pandolfo M, Mokini V, Novelli G, Hentati F, Ben Hamida M, Mandel J-L, K&#x00153;nig M. Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. <span><span class="ref-journal">Nat Genet. </span>1993;<span class="ref-vol">5</span>:195–200.</span> [<a href="/pubmed/8252047" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8252047</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.benomar.2002.25">Benomar A, Yahyaoui M, Meggouh F, Bouhouche A, Boutchich M, Bouslam N, Zaim A, Schmitt M, Belaidi H, Ouazzani R, Chkili T, Koenig M. Clinical comparison between AVED patients with 744 del A mutation and Friedreich ataxia with GAA expansion in 15 Moroccan families. <span><span class="ref-journal">J Neurol Sci. </span>2002;<span class="ref-vol">198</span>:25–9.</span> [<a href="/pubmed/12039660" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12039660</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.bomar.2003.264">Bomar JM, Benke PJ, Slattery EL, Puttagunta R, Taylor LP, Seong E, Nystuen A, Chen W, Albin RL, Patel PD, Kittles RA, Sheffield VC, Burmeister M. Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">35</span>:264–9.</span> [<a href="/pubmed/14556008" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14556008</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.burck.1981.267">Burck U, Goebel HH, Kuhlendahl HD, Meier C, Goebel KM. Neuromyopathy and vitamin E deficiency in man. <span><span class="ref-journal">Neuropediatrics. </span>1981;<span class="ref-vol">12</span>:267–78.</span> [<a href="/pubmed/6945489" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6945489</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.cavalier.1998.301">Cavalier L, Ouahchi K, Kayden HJ, Di Donato S, Reutenauer L, Mandel JL, Koenig M. Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">62</span>:301–10.</span> [<a href="/pmc/articles/PMC1376876/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1376876</span></a>] [<a href="/pubmed/9463307" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9463307</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.copp.1999.80">Copp RP, Wisniewski T, Hentati F, Larnaout A, Ben Hamida M, Kayden HJ. Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders. <span><span class="ref-journal">Brain Res. </span>1999;<span class="ref-vol">822</span>:80–7.</span> [<a href="/pubmed/10082886" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10082886</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.crabb.1988.18678">Crabb JW, Johnson CM, Carr SA, Armes LG, Saari JC. The complete primary structure of the cellular retinaldehyde-binding protein from bovine retina. <span><span class="ref-journal">J Biol Chem. </span>1988;<span class="ref-vol">263</span>:18678–87.</span> [<a href="/pubmed/3198594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3198594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.debant.1996.5466">Debant A, Serra-Pages C, Seipel K, O'Brien S, Tang M, Park SH, Streuli M. The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1996;<span class="ref-vol">93</span>:5466–71.</span> [<a href="/pmc/articles/PMC39269/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC39269</span></a>] [<a href="/pubmed/8643598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8643598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.el_euchfayache.2014.402">El Euch-Fayache G, Bouhlal Y, Amouri R, Feki M, Hentati F. Molecular, clinical and peripheral neuropathy study of Tunisian patient with ataxia with vitamin E deficiency. <span><span class="ref-journal">Brain. </span>2014;<span class="ref-vol">137</span>:402–10.</span> [<a href="/pubmed/24369383" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24369383</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.elkamil.2015.33">Elkamil A, Johansen KK, Aasly J. Ataxia with vitamin e deficiency in norway. <span><span class="ref-journal">J Mov Disord. </span>2015;<span class="ref-vol">8</span>:33–6.</span> [<a href="/pmc/articles/PMC4298717/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4298717</span></a>] [<a href="/pubmed/25614784" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25614784</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.finckh.1995.210">Finckh B, Kontush A, Commentz J, Hubner C, Burdelski M, Kohlschutter A. Monitoring of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma microsamples using high-performance liquid chromatography with coulometric electrochemical detection. <span><span class="ref-journal">Anal Biochem. </span>1995;<span class="ref-vol">232</span>:210–6.</span> [<a href="/pubmed/8747477" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8747477</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.gabsi.2001.477">Gabsi S, Gouider-Khouja N, Belal S, Fki M, Kefi M, Turki I, Ben Hamida M, Kayden H, Mebazaa R, Hentati F. Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency. <span><span class="ref-journal">Eur J Neurol. </span>2001;<span class="ref-vol">8</span>:477–81.</span> [<a href="/pubmed/11554913" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11554913</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.gotoda.1995.1313">Gotoda T, Arita M, Arai H, Inoue K, Yokota T, Fukuo Y, Yazaki Y, Yamada N. Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein. <span><span class="ref-journal">N Engl J Med. </span>1995;<span class="ref-vol">333</span>:1313–8.</span> [<a href="/pubmed/7566022" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7566022</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.harding.1985.32">Harding AE, Matthews S, Jones S, Ellis CJ, Booth IW, Muller DP. Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. <span><span class="ref-journal">N Engl J Med. </span>1985;<span class="ref-vol">313</span>:32–5.</span> [<a href="/pubmed/4000224" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4000224</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.hentati.1996.295">Hentati A, Deng HX, Hung WY, Nayer M, Ahmed MS, He X, Tim R, Stumpf DA, Siddique T. Ahmed. Human alpha-tocopherol transfer protein: gene structure and mutations in familial vitamin E deficiency. <span><span class="ref-journal">Ann Neurol. </span>1996;<span class="ref-vol">39</span>:295–300.</span> [<a href="/pubmed/8602747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8602747</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.herbas.2010a.200">Herbas MS, Okazaki M, Terao E, Xuan X, Arai H, Suzuki H. Alpha-tocopherol transfer protein inhibition is effective in the prevention of cerebral malaria in mice. <span><span class="ref-journal">Am J Clin Nutr. </span>2010a;<span class="ref-vol">91</span>:200–7.</span> [<a href="/pubmed/19923370" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19923370</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.herbas.2010b.101">Herbas MS, Ueta YY, Ichikawa C, Chiba M, Ishibashi K, Shichiri M, Fukumoto S, Yokoyama N, Takeya M, Xuan X, Arai H, Suzuki H. Alpha-tocopherol transfer protein disruption confers resistance to malarial infection in mice. <span><span class="ref-journal">Malar J. </span>2010b;<span class="ref-vol">9</span>:101.</span> [<a href="/pmc/articles/PMC2862040/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2862040</span></a>] [<a href="/pubmed/20403155" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20403155</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.hosomi.1997.105">Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O, Arai H, Inoue K. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. <span><span class="ref-journal">FEBS Lett. </span>1997;<span class="ref-vol">409</span>:105–8.</span> [<a href="/pubmed/9199513" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9199513</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.hosomi.1998.159">Hosomi A, Goto K, Kondo H, Iwatsubo T, Yokota T, Ogawa M, Arita M, Aoki J, Arai H, Inoue K. Localization of alpha-tocopherol transfer protein in rat brain. <span><span class="ref-journal">Neurosci Lett. </span>1998;<span class="ref-vol">256</span>:159–62.</span> [<a href="/pubmed/9855364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9855364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.kaempfrotzoll.2003.439">Kaempf-Rotzoll DE, Horiguchi M, Hashiguchi K, Aoki J, Tamai H, Linderkamp O, Arai H. Human placental trophoblast cells express alpha-tocopherol transfer protein. <span><span class="ref-journal">Placenta. </span>2003;<span class="ref-vol">24</span>:439–44.</span> [<a href="/pubmed/12744919" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12744919</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.kara.2008.471">Kara B, Uz&#x000fc;mc&#x000fc; A, Uyguner O, Rosti RO, Ko&#x000e7;ba&#x0015f; A, Ozmen M, Kayserili H. Ataxia with vitamin E deficiency associated with deafness. <span><span class="ref-journal">Turk J Pediatr. </span>2008;<span class="ref-vol">50</span>:471–5.</span> [<a href="/pubmed/19102053" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19102053</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.kohlsch_tter.1997.581">Kohlsch&#x000fc;tter A, Mayatepek E, Finckh B, Hubner C. Effect of plasma alpha-tocopherol on leukotriene E4 excretion in genetic vitamin E deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>1997;<span class="ref-vol">20</span>:581–6.</span> [<a href="/pubmed/9266396" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9266396</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.larnaout.1997.633">Larnaout A, Belal S, Zouari M, Fki M, Ben Hamida C, Goebel HH, Ben Hamida M, Hentati F. Friedreich's ataxia with isolated vitamin E deficiency: a neuropathological study of a Tunisian patient. <span><span class="ref-journal">Acta Neuropathol (Berl). </span>1997;<span class="ref-vol">93</span>:633–7.</span> [<a href="/pubmed/9194904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9194904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.leonard.2002.555">Leonard SW, Terasawa Y, Farese RV Jr, Traber MG. Incorporation of deuterated. <span><span class="ref-journal">Am J Clin Nutr. </span>2002;<span class="ref-vol">75</span>:555–60.</span> [<a href="/pubmed/11864863" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11864863</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.l_pez.2010.1">L&#x000f3;pez C, Saravia C, Gomez A, Hoebeke J, Patarroyo MA. Mechanisms of genetically-based resistance to malaria. <span><span class="ref-journal">Gene. </span>2010;<span class="ref-vol">467</span>:1–12.</span> [<a href="/pubmed/20655368" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20655368</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.mariotti.2004.130">Mariotti C, Gellera C, Rimoldi M, Mineri R, Uziel G, Zorzi G, Pareyson D, Piccolo G, Gambi D, Piacentini S, Squitieri F, Capra R, Castellotti B, Di Donato S. Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. <span><span class="ref-journal">Neurol Sci. </span>2004;<span class="ref-vol">25</span>:130–7.</span> [<a href="/pubmed/15300460" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15300460</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.marzouki.2005.21">Marzouki N, Benomar A, Yahyaoui M, Birouk N, Elouazzani M, Chkili T, Benlemlih M. Vitamin E deficiency ataxia with (744 del A) mutation on alpha-TTP gene: genetic and clinical peculiarities in Moroccan patients. <span><span class="ref-journal">Eur J Med Genet. </span>2005;<span class="ref-vol">48</span>:21–8.</span> [<a href="/pubmed/15953402" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15953402</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.meier.2003.725">Meier R, Tomizaki T, Schulze-Briese C, Baumann U, Stocker A. The molecular basis of vitamin E retention: structure of human alpha-tocopherol transfer protein. <span><span class="ref-journal">J Mol Biol. </span>2003;<span class="ref-vol">331</span>:725–34.</span> [<a href="/pubmed/12899840" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12899840</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.min.2003.14713">Min KC, Kovall RA, Hendrickson WA. Crystal structure of human alpha-tocopherol transfer protein bound to its ligand: implications for ataxia with vitamin E deficiency. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2003;<span class="ref-vol">100</span>:14713–8.</span> [<a href="/pmc/articles/PMC299775/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC299775</span></a>] [<a href="/pubmed/14657365" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14657365</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.morley.2004.4143">Morley S, Panagabko C, Shineman D, Mani B, Stocker A, Atkinson J, Manor D. Molecular determinants of heritable vitamin E deficiency. <span><span class="ref-journal">Biochemistry. </span>2004;<span class="ref-vol">43</span>:4143–9.</span> [<a href="/pubmed/15065857" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15065857</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.m_llerschmehl.2004.413">M&#x000fc;ller-Schmehl K, Beninde J, Finckh B, Florian S, Dudenhausen JW, Brigelius-Floh&#x000e9; R, Schuelke M. Localization of alpha-tocopherol transfer protein in trophoblast, fetal capillaries' endothelium and amnion epithelium of human term placenta. <span><span class="ref-journal">Free Radic Res. </span>2004;<span class="ref-vol">38</span>:413–20.</span> [<a href="/pubmed/15190938" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15190938</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.ouahchi.1995.141">Ouahchi K, Arita M, Kayden H, Hentati F, Ben Hamida M, Sokol R, Arai H, Inoue K, Mandel JL, Koenig M. Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. <span><span class="ref-journal">Nat Genet. </span>1995;<span class="ref-vol">9</span>:141–5.</span> [<a href="/pubmed/7719340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7719340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.qian.2006.8236">Qian J, Atkinson J, Manor D. Biochemical consequences of heritable mutations in the alpha-tocopherol transfer protein. <span><span class="ref-journal">Biochemistry. </span>2006;<span class="ref-vol">45</span>:8236–42.</span> [<a href="/pubmed/16819822" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16819822</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.sato.1993.17705">Sato Y, Arai H, Miyata A, Tokita S, Yamamoto K, Tanabe T, Inoue K. Primary structure of alpha-tocopherol transfer protein from rat liver. Homology with cellular retinaldehyde-binding protein. <span><span class="ref-journal">J Biol Chem. </span>1993;<span class="ref-vol">268</span>:17705–10.</span> [<a href="/pubmed/8349655" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8349655</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.schuelke.2000a.1543">Schuelke M, Elsner A, Finckh B, Kohlschutter A, Hubner C, Brigelius-Flohe R. Urinary alpha-tocopherol metabolites in alpha-tocopherol transfer protein-deficient patients. <span><span class="ref-journal">J Lipid Res. </span>2000a;<span class="ref-vol">41</span>:1543–51.</span> [<a href="/pubmed/11013295" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11013295</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.schuelke.2000b.1584">Schuelke M, Finckh B, Sistermans EA, Ausems MG, Hubner C, von Moers A. Ataxia with vitamin E deficiency: biochemical effects of malcompliance with vitamin E therapy. <span><span class="ref-journal">Neurology. </span>2000b;<span class="ref-vol">55</span>:1584–6.</span> [<a href="/pubmed/11094124" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11094124</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.schuelke.1999.240">Schuelke M, Mayatepek E, Inter M, Becker M, Pfeiffer E, Speer A, Hubner C, Finckh B. Treatment of ataxia in isolated vitamin E deficiency caused by alpha-tocopherol transfer protein deficiency. <span><span class="ref-journal">J Pediatr. </span>1999;<span class="ref-vol">134</span>:240–4.</span> [<a href="/pubmed/9931538" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9931538</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.sha.1998.506">Sha B, Phillips SE, Bankaitis VA, Luo M. Crystal structure of the Saccharomyces cerevisiae phosphatidylinositol-transfer protein. <span><span class="ref-journal">Nature. </span>1998;<span class="ref-vol">391</span>:506–10.</span> [<a href="/pubmed/9461221" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9461221</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.sharpe.1996.223">Sharpe PC, Duly EB, MacAuley D, McCrum EE, Mulholland C, Stott G, Boreham CA, Kennedy G, Evans AE, Trinick TR. Total radical trapping antioxidant potential (TRAP) and exercise. <span><span class="ref-journal">QJM. </span>1996;<span class="ref-vol">89</span>:223–8.</span> [<a href="/pubmed/8731567" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8731567</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.shorer.1996.340">Shorer Z, Parvari R, Bril G, Sela BA, Moses S. Ataxia with isolated vitamin E deficiency in four siblings. <span><span class="ref-journal">Pediatr Neurol. </span>1996;<span class="ref-vol">15</span>:340–3.</span> [<a href="/pubmed/8972536" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8972536</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.thakur.2010.9339">Thakur V, Morley S, Manor D. Hepatic &#x003b1;-tocopherol transfer protein: ligand-induced protection from proteasomal degradation. <span><span class="ref-journal">Biochemistry. </span>2010;<span class="ref-vol">49</span>:9339–44.</span> [<a href="/pmc/articles/PMC2964440/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2964440</span></a>] [<a href="/pubmed/20828164" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20828164</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.traber.1990.397">Traber MG, Sokol RJ, Burton GW, Ingold KU, Papas AM, Huffaker JE, Kayden HJ. Impaired ability of patients with familial isolated vitamin E deficiency to incorporate alpha-tocopherol into lipoproteins secreted by the liver. <span><span class="ref-journal">J Clin Invest. </span>1990;<span class="ref-vol">85</span>:397–407.</span> [<a href="/pmc/articles/PMC296438/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC296438</span></a>] [<a href="/pubmed/2298915" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2298915</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.traber.1993.201">Traber MG, Sokol RJ, Kohlschutter A, Yokota T, Muller DP, Dufour R, Kayden HJ. Impaired discrimination between stereoisomers of alpha-tocopherol in patients with familial isolated vitamin E deficiency. <span><span class="ref-journal">J Lipid Res. </span>1993;<span class="ref-vol">34</span>:201–10.</span> [<a href="/pubmed/8429255" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8429255</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.traber.2012.330">Traber MG, Manor D. Vitamin E. <span><span class="ref-journal">Adv Nutr. </span>2012;<span class="ref-vol">3</span>:330–1.</span> [<a href="/pmc/articles/PMC3649464/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3649464</span></a>] [<a href="/pubmed/22585906" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22585906</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.ulatowski.2014.120">Ulatowski L, Parker R, Warrier G, Sultana R, Butterfield DA, Manor D. Vitamin E is essential for Purkinje neuron integrity. <span><span class="ref-journal">Neuroscience. </span>2014;<span class="ref-vol">260</span>:120–9.</span> [<a href="/pmc/articles/PMC3943241/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3943241</span></a>] [<a href="/pubmed/24342566" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24342566</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.usuki.2000.254">Usuki F, Maruyama K. Ataxia caused by mutations in the alpha-tocopherol transfer protein gene. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2000;<span class="ref-vol">69</span>:254–6.</span> [<a href="/pmc/articles/PMC1737064/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1737064</span></a>] [<a href="/pubmed/10896705" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10896705</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.weiser.1996.2539">Weiser H, Riss G, Kormann AW. Biodiscrimination of the eight alpha-tocopherol stereoisomers results in preferential accumulation of the four 2R forms in tissues and plasma of rats. <span><span class="ref-journal">J Nutr. </span>1996;<span class="ref-vol">126</span>:2539–49.</span> [<a href="/pubmed/8857515" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8857515</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.yokota.2000.521">Yokota T, Uchihara T, Kumagai J, Shiojiri T, Pang JJ, Arita M, Arai H, Hayashi M, Kiyosawa M, Okeda R, Mizusawa H. Postmortem study of ataxia with retinitis pigmentosa by mutation of the alpha-tocopherol transfer protein gene. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2000;<span class="ref-vol">68</span>:521–5.</span> [<a href="/pmc/articles/PMC1736898/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1736898</span></a>] [<a href="/pubmed/10727494" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10727494</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.zimmer.2000.25672">Zimmer S, Stocker A, Sarbolouki MN, Spycher SE, Sassoon J, Azzi A. A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. <span><span class="ref-journal">J Biol Chem. </span>2000;<span class="ref-vol">275</span>:25672–80.</span> [<a href="/pubmed/10829015" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10829015</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="aved.REF.zortea.2004.275">Zortea M, Armani M, Pastorello E, Nunez GF, Lombardi S, Tonello S, Rigoni MT, Zuliani L, Mostacciuolo ML, Gellera C, Di Donato S, Trevisan CP. Prevalence of inherited ataxias in the province of Padua, Italy. <span><span class="ref-journal">Neuroepidemiology. </span>2004;<span class="ref-vol">23</span>:275–80.</span> [<a href="/pubmed/15297793" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15297793</span></a>]</div></li></ul></div></div><div id="aved.Chapter_Notes"><h2 id="_aved_Chapter_Notes_">Chapter Notes</h2><div id="aved.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>13 October 2016 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>2 November 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>4 September 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 May 2005 (me) Review posted live</div></li><li class="half_rhythm"><div>4 October 2004 (ms) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1241</span><span class="label">PMID: <a href="/pubmed/20301419" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301419</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/aoa2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ataxia-telangiectas/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1241&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1241/?report=reader">PubReader</a></li><li><a href="/books/NBK1241/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1241" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1241" style="display:none" title="Cite this Page"><div class="bk_tt">Schuelke M. Ataxia with Vitamin E Deficiency. 2005 May 20 [Updated 2016 Oct 13]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1241/pdf/Bookshelf_NBK1241.pdf">PDF version of this page</a> (480K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#aved.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#aved.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#aved.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#aved.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#aved.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#aved.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#aved.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#aved.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#aved.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#aved.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#aved.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7274[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TTPA</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1241+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1470404" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1470404" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1470404" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1470404" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30358967" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Abetalipoproteinemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Abetalipoproteinemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Burnett JR, Hooper AJ, Hegele RA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21634085" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Herbert M, Goldstein JL, Rehder C, Austin S, Kishnani PS, Bali DS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31393689" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Adenosine Deaminase 2 Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Adenosine Deaminase 2 Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Aksentijevich I, Sampaio Moura N, Barron K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24260777" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Biotin-Thiamine-Responsive Basal Ganglia Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Biotin-Thiamine-Responsive Basal Ganglia Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tabarki B, Al-Hashem A, Alfadhel M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301481" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophic Epidermolysis Bullosa</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophic Epidermolysis Bullosa<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pfendner EG, Lucky AW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301419" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301419" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041a74dde089116963253c">Ataxia with Vitamin E Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Ataxia with Vitamin E Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:27:00-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C09BDE04153D100000000021200C0&amp;ncbi_session=CE8C09BDE041A731_0530SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1241%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1241&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1241/&amp;ncbi_pagename=Ataxia with Vitamin E Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C09BDE041A731_0530SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>